# Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

> **NCT05251233** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 56 (actual)

## Conditions studied

- Pancreatic Cancer
- Pancreas Cancer
- Ampullary Cancer
- Pancreas Neuroendocrine Tumor
- Pancreatitis
- Distal Extrahepatic Cholangiocarcinoma
- Duodenal Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT05251233
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-21
- **Primary completion:** 2024-06-29
- **Final completion:** 2024-06-29
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Investigator and study team chose to end study early.
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05251233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05251233, "Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05251233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*